Free CME from PeerView


Surgery CME

Credits: 0.5 CME
Medical Learning Institute, Inc.
Visualizing Progress in the Treatment of Chronic Active Antibody-Mediated Rejection: A Closer Look at the Clinical Potential of Targeting IL-6 to Improve Outcomes in the Kidney Transplant Setting
Stanley C. Jordan, MD, FASN, FAST
May 11, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Neoadjuvant, Adjuvant, or Both: How to Solve the Puzzle of Perioperative Immunotherapy, Individualize Treatment Plans, and Improve Cure Rates in Resectable NSCLC
Jonathan D. Spicer, MD, PhD, FRCSC
May 06, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Navigating Complex Decisions at the Intersection of Local and Systemic Management of Early Breast Cancer
Laura S. Dominici, MD, FACS
March 24, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
Overcoming GVHD Is the Key to Better HCT Outcomes: Guidance on Managing Acute and Chronic Disease
Stephanie Lee, MD, MPH
March 22, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Harnessing the Power of Immunotherapy in Resectable Melanoma: Guidance for Delivering Effective Adjuvant and Neoadjuvant Strategies
Jennifer Wargo, MD, MMSc
March 22, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Shaping Modern Management of Myelofibrosis: Guidance on the Conjunction of Targeted Therapy and AlloHCT
Aaron T. Gerds, MD, MS / John Mascarenhas, MD
March 16, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
The Time Is Now for Outpatient CAR-T: Essential Infrastructure, Lessons From Transplant, and New Evidence
Olalekan Oluwole, MBBS, MD
March 16, 2023
Credits: 1.0 CME / CC
PVI, PeerView Institute for Medical Education
Gaining Confidence in Predicting and Assessing Response to Cancer Immunotherapies: Practical Strategies for Biomarker Testing and Pathologic Response Assessment
Tricia Cottrell, MD, MPH / Lynette M. Sholl, MD
March 14, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
New Rules for VOD/SOS: Modern Risk Assessment, Diagnostic Principles, and Innovative Treatment
Prof. Mohamad Mohty / Christine N. Duncan, MD
March 13, 2023
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Addressing Key Questions About the Latest Diagnostic and Therapeutic Advances in Desmoid Tumors
Ravin Ratan, MD, M.Ed
February 23, 2023
Credits: 1.0 CME
The Medical College of Wisconsin
Hitting the BCMA Target in Multiple Myeloma: Insights on CAR-T Therapy and Innovative Antibody Options
Thomas G. Martin, III, MD / Krina Patel, MD, MSc
February 15, 2023
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC: How to Modernize Best Practices Based on New Evidence and Better Multidisciplinary Alliances
Nasser Altorki, MD / Jonathan D. Spicer, MD, PhD, FRCSC
January 21, 2023
Credits: 1.25 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Critical Conversations on Venous Thromboembolism: A MasterClass Series on DVT and PE
Alexander (Ander) T. Cohen, MBBS, MSc, MD, FRACP, FESC, FRCP
December 16, 2022
Credits: 1.5 CME / MOC
PSU, Penn State University
The Future is Now in MDS: Integrating Innovative, Risk-Adapted Therapies Into Patient Management
Guillermo Garcia-Manero, MD
December 09, 2022
Credits: 1.5 CME / MOC
Penn State College of Medicine
Maintaining “Intensity” for Better Outcomes in AML: Guidance on Modern, Intensive Upfront Platforms in Challenging Patient Populations
Gail J. Roboz, MD
December 09, 2022
Credits: 2.0 CME / MOC
PVI, PeerView Institute for Medical Education
Clarifying the Complexities of the Expanding Treatment Options for Advanced- and Early-Stage HR+/HER2- Breast Cancer
Erika Hamilton, MD
December 07, 2022
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
On the Cusp of Change: Modernizing the Treatment of Desmoid Tumors With Novel Gamma Secretase Inhibitors
Bernd Kasper, MD, PhD
November 30, 2022
Credits: 1.0 CME / MOC
Johns Hopkins University School of Medicine
Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your Knowledge
Shmuel Shoham, MD
July 08, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Navigating the Shifting Treatment Paradigm in ER+/HER2- Breast Cancer: Harnessing Modern Treatment Options and the Expanding Evidence Base to Better Patient Care and Outcomes in Early and Advanced Disease
Aditya Bardia, MD, MPH
June 16, 2022
PVI, PeerView Institute for Medical Education
The Power and Promise of Immunotherapy in Head and Neck Cancer: How Established and Emerging Immune-Based Options Can Enhance Patient Care
Robert I. Haddad, MD
June 05, 2022
The Medical College of Wisconsin
The Modern Management of Myelofibrosis: Practical Perspectives Surrounding the Use of JAK Inhibitors and Novel Therapeutics in the Peri-Transplant Setting
Jeanne M. Palmer, MD
May 27, 2022
The Medical College of Wisconsin
CAR-T Cell Therapy: Are You Up to the Challenge? New Evidence and Best Practices Driving Modern Cellular Therapies as a Standard of Care for Leukemia and Lymphoma
Michael R. Bishop, MD
May 25, 2022
The Medical College of Wisconsin
Upgrading the VOD/SOS Management Tool Kit: Guidance for Effective Diagnostic Confirmation, Grading, and Treatment
Nelson Chao, MD, MBA
April 26, 2022
PVI, PeerView Institute for Medical Education
Parsing the Practicalities of Pathologic Response Assessment After Neoadjuvant Immunotherapy to Facilitate Progress in Early-Stage Cancers
Prof. Solange Peters, MD, PhD
April 10, 2022
PVI, PeerView Institute for Medical Education
Primary Care Call to Action for VTE Management: Sharpening Skills in Recognition, Treatment, and Secondary Prevention
Geoffrey Barnes, MD, MSc
March 31, 2022
Penn State College of Medicine
Hope Is on the Horizon: The Clinical Potential of Emerging Disease-Modifying Therapies for Managing Complement 3 Glomerulopathy
Carla M. Nester, MD, MSA, FASN
February 24, 2022
Medical Learning Institute, Inc.
Can the Addition of Immunotherapy to Multimodal Management of Stage I-III NSCLC Help Break the Stalled Cycle of Poor Outcomes?
Nasser Altorki, MD / Jonathan D. Spicer, MD, PhD, FRCSC
February 22, 2022
University of Florida College of Medicine
Short Bowel Syndrome IMPACT Initiative: An Initiative to Individualize Treatment and Improve the Pediatric to Adult Healthcare Transition
Sam Cheng, MD / Angela Pham, MD
February 16, 2022
William D. Tap, MD
Medical Learning Institute, Inc.
Practice Points in TGCT: Updates on Safe Use of Novel Systemic Options
William D. Tap, MD
January 13, 2022
Medical Learning Institute, Inc.
New Advances and Opportunities for Improvement in HR+/HER2- Early Breast Cancer: Practical Strategies for Optimal Clinical Integration of Adjuvant CDK4 and 6 Inhibitor Therapy
Sara M. Tolaney, MD, MPH
December 28, 2021

Pages

Upcoming Live Events

Education Collections

More Education Collections

Recent CME Podcast

More Podcasts from PeerView